Nevertheless, the links between AIF1 and clinical adiposity, the relatively restricted pattern of AIF1 expression, and the apparently benign baseline phenotype of Aif1−/− mice suggest that methods to interrupt its effects on gene expression could provide a useful approach toward the mitigation of obesity. The gene discussed is AIF1; the disease is obesity disorder.